{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Salvia rosmarinus", "KCNQ4", "KCNQ5", "herbal medicine", "vasorelaxant"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37535015", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "04"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "29"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1096/fj.202301132R"], "Journal": {"ISSN": "1530-6860", "JournalIssue": {"Volume": "37", "Issue": "9", "PubDate": {"Year": "2023", "Month": "Sep"}}, "Title": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology", "ISOAbbreviation": "FASEB J"}, "ArticleTitle": "Medicinal plant rosemary relaxes blood vessels by activating vascular smooth muscle KCNQ channels.", "Pagination": {"StartPage": "e23125", "MedlinePgn": "e23125"}, "Abstract": {"AbstractText": ["The evergreen plant rosemary (Salvia rosmarinus) has been employed medicinally for centuries as a memory aid, analgesic, spasmolytic, vasorelaxant and antihypertensive, with recent preclinical and clinical evidence rationalizing some applications. Voltage-gated potassium (Kv) channels in the KCNQ (Kv7) subfamily are highly influential in the nervous system, muscle and epithelia. KCNQ4 and KCNQ5 regulate vascular smooth muscle excitability and contractility and are implicated as antihypertensive drug targets. Here, we found that rosemary extract potentiates homomeric and heteromeric KCNQ4 and KCNQ5 activity, resulting in membrane hyperpolarization. Two rosemary diterpenes, carnosol and carnosic acid, underlie the effects and, like rosemary, are efficacious KCNQ-dependent vasorelaxants, quantified by myography in rat mesenteric arteries. Sex- and estrous cycle stage-dependence of the vasorelaxation matches sex- and estrous cycle stage-dependent KCNQ expression. The results uncover a molecular mechanism underlying rosemary vasorelaxant effects and identify new chemical spaces for KCNQ-dependent vasorelaxants."], "CopyrightInformation": "\u00a9 2023 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, California, USA."}], "LastName": "Manville", "ForeName": "R\u00edan W", "Initials": "RW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Vascular Biology Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark."}], "LastName": "Baldwin", "ForeName": "Samuel N", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Vascular Biology Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark."}], "LastName": "Eriksen", "ForeName": "Emil \u00d8rnberg", "Initials": "E\u00d8"}, {"Identifier": ["0000-0002-9903-714X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Vascular Biology Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark."}], "LastName": "Jepps", "ForeName": "Thomas A", "Initials": "TA"}, {"Identifier": ["0000-0003-4552-496X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, California, USA."}], "LastName": "Abbott", "ForeName": "Geoffrey W", "Initials": "GW"}], "GrantList": [{"GrantID": "R35 GM130377", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "FASEB J", "NlmUniqueID": "8804484", "ISSNLinking": "0892-6638"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "KCNQ Potassium Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["physiology"], "DescriptorName": "Muscle, Smooth, Vascular"}, {"QualifierName": [], "DescriptorName": "Rosmarinus"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "KCNQ Potassium Channels"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasodilator Agents"}], "CoiStatement": "<b>Competing Interests:</b> The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbott GW. Biology of the KCNQ1 potassium channel. New Journal of Science. 2014;2014(Article ID 237431):26. doi:10.1155/2014/237431", "ArticleIdList": ["10.1155/2014/237431"]}, {"Citation": "Abbott GW. KCNQs: Ligand- and Voltage-Gated Potassium Channels. Front Physiol. 2020;11:583. doi:10.3389/fphys.2020.00583", "ArticleIdList": ["10.3389/fphys.2020.00583", "PMC7324551", "32655402"]}, {"Citation": "Abbott GW. Kv Channel Ancillary Subunits: Where Do We Go from Here? Physiology (Bethesda). Sep 1 2022;37(5):0. doi:10.1152/physiol.00005.2022", "ArticleIdList": ["10.1152/physiol.00005.2022", "PMC9394777", "35797055"]}, {"Citation": "Brueggemann LI, Mackie AR, Cribbs LL, et al. Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J Biol Chem. Jan 24 2014;289(4):2099\u2013111. doi:10.1074/jbc.M113.527820", "ArticleIdList": ["10.1074/jbc.M113.527820", "PMC3900957", "24297175"]}, {"Citation": "Chadha PS, Jepps TA, Carr G, et al. Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity. Arterioscler Thromb Vasc Biol. Apr 2014;34(4):887\u201393. doi:10.1161/ATVBAHA.114.303405", "ArticleIdList": ["10.1161/ATVBAHA.114.303405", "24558103"]}, {"Citation": "Abbott GW, Jepps TA. Kcne4 Deletion Sex-Dependently Alters Vascular Reactivity. J Vasc Res. 2016;53(3\u20134):138\u2013148. doi:10.1159/000449060", "ArticleIdList": ["10.1159/000449060", "PMC5166573", "27710966"]}, {"Citation": "Jepps TA, Carr G, Lundegaard PR, Olesen SP, Greenwood IA. Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone. J Physiol. Dec 15 2015;593(24):5325\u201340. doi:10.1113/JP271286", "ArticleIdList": ["10.1113/JP271286", "PMC4704525", "26503181"]}, {"Citation": "Byron KL, Brueggemann LI. Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone. Microcirculation. Jan 2018;25(1)doi:10.1111/micc.12419", "ArticleIdList": ["10.1111/micc.12419", "28976052"]}, {"Citation": "Chadha PS, Zunke F, Zhu HL, et al. Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired beta-adrenoceptor-mediated relaxation of renal arteries in hypertension. Hypertension. Apr 2012;59(4):877\u201384. doi:10.1161/HYPERTENSIONAHA.111.187427", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.111.187427", "22353613"]}, {"Citation": "Lindman J, Khammy MM, Lundegaard PR, Aalkjaer C, Jepps TA. Microtubule Regulation of Kv7 Channels Orchestrates cAMP-Mediated Vasorelaxations in Rat Arterial Smooth Muscle. Hypertension. Feb 2018;71(2):336\u2013345. doi:10.1161/HYPERTENSIONAHA.117.10152", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.117.10152", "29279314"]}, {"Citation": "van der Horst J, Greenwood IA, Jepps TA. Cyclic AMP-Dependent Regulation of Kv7 Voltage-Gated Potassium Channels. Front Physiol. 2020;11:727. doi:10.3389/fphys.2020.00727", "ArticleIdList": ["10.3389/fphys.2020.00727", "PMC7338754", "32695022"]}, {"Citation": "van der Horst J, Rognant S, Abbott GW, et al. Dynein regulates Kv7.4 channel trafficking from the cell membrane. J Gen Physiol. Mar 1 2021;153(3)doi:10.1085/jgp.202012760", "ArticleIdList": ["10.1085/jgp.202012760", "PMC7863719", "33533890"]}, {"Citation": "Baldwin SN, Forrester EA, Homer NZM, et al. Marked oestrous cycle-dependent regulation of rat arterial K(V) 7.4 channels driven by GPER1. Br J Pharmacol. Jan 2023;180(2):174\u2013193. doi:10.1111/bph.15947", "ArticleIdList": ["10.1111/bph.15947", "PMC10091994", "36085551"]}, {"Citation": "Baldwin SN, Jepps TA, Greenwood IA. Cycling matters: Sex hormone regulation of vascular potassium channels. Channels (Austin). Dec 2023;17(1):2217637. doi:10.1080/19336950.2023.2217637", "ArticleIdList": ["10.1080/19336950.2023.2217637", "PMC10228406", "37243715"]}, {"Citation": "Barrese V, Stott JB, Figueiredo HB, et al. Angiotensin II Promotes K(V)7.4 Channels Degradation Through Reduced Interaction With HSP90 (Heat Shock Protein 90). Hypertension. Jun 2018;71(6):1091\u20131100. doi:10.1161/HYPERTENSIONAHA.118.11116", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.118.11116", "PMC6390948", "29686000"]}, {"Citation": "Jepps TA, Chadha PS, Davis AJ, et al. Downregulation of kv7.4 channel activity in primary and secondary hypertension. Circulation. Aug 2 2011;124(5):602\u201311. doi:10.1161/CIRCULATIONAHA.111.032136", "ArticleIdList": ["10.1161/CIRCULATIONAHA.111.032136", "21747056"]}, {"Citation": "Khanamiri S, Soltysinska E, Jepps TA, et al. Contribution of Kv7 channels to basal coronary flow and active response to ischemia. Hypertension. Dec 2013;62(6):1090\u20137. doi:10.1161/HYPERTENSIONAHA.113.01244", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.113.01244", "24082059"]}, {"Citation": "Stott JB, Barrese V, Jepps TA, Leighton EV, Greenwood IA. Contribution of Kv7 channels to natriuretic peptide mediated vasodilation in normal and hypertensive rats. Hypertension. Mar 2015;65(3):676\u201382. doi:10.1161/HYPERTENSIONAHA.114.04373", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.114.04373", "25547342"]}, {"Citation": "Manville RW, Redford KE, van der Horst J, Hogenkamp DJ, Jepps TA, Abbott GW. KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine. FASEB J. Sep 2022;36(9):e22457. doi:10.1096/fj.202200724R", "ArticleIdList": ["10.1096/fj.202200724R", "PMC9404676", "35997997"]}, {"Citation": "Manville RW, van der Horst J, Redford KE, Katz BB, Jepps TA, Abbott GW. KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines. Proc Natl Acad Sci U S A. Oct 15 2019;116(42):21236\u201321245. doi:10.1073/pnas.1907511116", "ArticleIdList": ["10.1073/pnas.1907511116", "PMC6800379", "31570602"]}, {"Citation": "Redford KE, Rognant S, Jepps TA, Abbott GW. KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea. Cell Physiol Biochem. Mar 6 2021;55(S3):46\u201364. doi:10.33594/000000337", "ArticleIdList": ["10.33594/000000337", "PMC8612027", "33667331"]}, {"Citation": "Bao TQ, Li Y, Qu C, Zheng ZG, Yang H, Li P. Antidiabetic Effects and Mechanisms of Rosemary (Rosmarinus officinalis L.) and its Phenolic Components. Am J Chin Med. 2020;48(6):1353\u20131368. doi:10.1142/S0192415X20500664", "ArticleIdList": ["10.1142/S0192415X20500664", "33016104"]}, {"Citation": "Prasannarong M, Saengsirisuwan V, Surapongchai J, Buniam J, Chukijrungroat N, Rattanavichit Y. Rosmarinic acid improves hypertension and skeletal muscle glucose transport in angiotensin II-treated rats. BMC Complement Altern Med. Jul 8 2019;19(1):165. doi:10.1186/s12906-019-2579-4", "ArticleIdList": ["10.1186/s12906-019-2579-4", "PMC6615279", "31286941"]}, {"Citation": "Han S, Li X, Xia Y, et al. Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells. J Med Chem. Dec 12 2019;62(23):10867\u201310896. doi:10.1021/acs.jmedchem.9b01405", "ArticleIdList": ["10.1021/acs.jmedchem.9b01405", "31725297"]}, {"Citation": "Cora MC, Kooistra L, Travlos G. Vaginal Cytology of the Laboratory Rat and Mouse: Review and Criteria for the Staging of the Estrous Cycle Using Stained Vaginal Smears. Toxicol Pathol. Aug 2015;43(6):776\u201393. doi:10.1177/0192623315570339", "ArticleIdList": ["10.1177/0192623315570339", "25739587"]}, {"Citation": "Manville RW, Hogenkamp DJ, Abbott GW. Ancient medicinal plant rosemary contains a highly efficacious and isoform-selective KCNQ potassium channel opener. Communications Biology. June 15 2023;6(1):644. doi: 10.1038/s42003-023-05021-8.", "ArticleIdList": ["10.1038/s42003-023-05021-8", "PMC10272180", "37322081"]}, {"Citation": "Bostock J, Riley HT. The Natural History. Pliny the Elder. Taylor & Francis; 1855."}, {"Citation": "Paine A Healing Plants of the Celtic Druids: Ancient Celts in Britain and Their Druid Healers Used Plant Medicine to Treat the Mind, Body and Soul. Moon Books; 2018."}, {"Citation": "Zhang J, Chen T, Li K, et al. Screening active ingredients of rosemary based on spectrum-effect relationships between UPLC fingerprint and vasorelaxant activity using three chemometrics. J Chromatogr B Analyt Technol Biomed Life Sci. Dec 15 2019;1134\u20131135:121854. doi:10.1016/j.jchromb.2019.121854", "ArticleIdList": ["10.1016/j.jchromb.2019.121854", "31785534"]}, {"Citation": "Ghasemzadeh Rahbardar M, Hosseinzadeh H. Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. Iran J Basic Med Sci. Sep 2020;23(9):1100\u20131112. doi:10.22038/ijbms.2020.45269.10541", "ArticleIdList": ["10.22038/ijbms.2020.45269.10541", "PMC7491497", "32963731"]}, {"Citation": "Solhi H, Salehi B, Alimoradian A, et al. Beneficial Effects of Rosmarinus Officinalis for Treatment of Opium Withdrawal Syndrome during Addiction Treatment Programs: A Clinical Trial. Addict Health. Summer-Autumn; 2013;5(3\u20134):90\u20134.", "ArticleIdList": ["PMC3905473", "24494164"]}, {"Citation": "Sinkovic A, Suran D, Lokar L, et al. Rosemary extracts improve flow-mediated dilatation of the brachial artery and plasma PAI-1 activity in healthy young volunteers. Phytother Res. Mar 2011;25(3):402\u20137. doi:10.1002/ptr.3276", "ArticleIdList": ["10.1002/ptr.3276", "20734322"]}, {"Citation": "Martelli A, Testai L, Breschi MC, et al. Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels. Pharmacol Res. Apr 2013;70(1):27\u201334. doi:10.1016/j.phrs.2012.12.005", "ArticleIdList": ["10.1016/j.phrs.2012.12.005", "23287425"]}, {"Citation": "Tang G, Wu L, Wang R. Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol. Jul 2010;37(7):753\u201363. doi:10.1111/j.1440-1681.2010.05351.x", "ArticleIdList": ["10.1111/j.1440-1681.2010.05351.x", "20636621"]}, {"Citation": "Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. Nov 1 2001;20(21):6008\u201316. doi:10.1093/emboj/20.21.6008", "ArticleIdList": ["10.1093/emboj/20.21.6008", "PMC125693", "11689441"]}, {"Citation": "Crump SM, Hu Z, Kant R, Levy DI, Goldstein SA, Abbott GW. Kcne4 deletion sex- and age-specifically impairs cardiac repolarization in mice. FASEB J. Jan 2016;30(1):360\u20139. doi:10.1096/fj.15-278754", "ArticleIdList": ["10.1096/fj.15-278754", "PMC4684512", "26399785"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "18"}, {"Year": "2023", "Month": "6", "Day": "7"}, {"Year": "2023", "Month": "7", "Day": "25"}, {"Year": "2024", "Month": "9", "Day": "1"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "3", "Hour": "13", "Minute": "8"}, {"Year": "2023", "Month": "8", "Day": "3", "Hour": "10", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37535015", "NIHMS1920603", "PMC10437472", "10.1096/fj.202301132R"]}}], "PubmedBookArticle": []}